You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

138 Results
Drug
Other Name(s): Alkeran®
Jun 2019
Drug
Other Name(s): Leukeran®
Nov 2024
Drug
Other Name(s): Xeloda®
Jul 2024
Drug
Other Name(s): Provera® (multiple brands available)
Apr 2015
Drug
Other Name(s): Megace® (multiple brands available)
Aug 2016
Drug
Other Name(s): Purinethol®
Jun 2019
Drug
Drug
Other Name(s): Procytox®
Oct 2020
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
  • megestrol - oral tablets
May 2016
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Funding:
ODB - General Benefit
  • prednisone
Apr 2016
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Adjuvant, Palliative
Funding:
ODB - General Benefit
    capecitabine
Jul 2024
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer
ODB - General Benefit
    capecitabine
Apr 2023

Pages